With Sidocel's innovative, next-generation immunotherapies, we’re redefining efficacy and safety through more targeted, effective, and safer interventions.
TRIDENT Platform
1. First Prong: Multi-TAA targeting
2. Second Prong: Superior CD3 nanobody
3. Third Prong: Killing enhanced booster
In Vivo Nanobody TCE Armored CAR-T
1. Prevents antigen escape through multi-targeting
2. Secreted small NTCEs penetrate solid tumors, activate bystander T cells, enhance potency, and reduce exhaustion
3. Targeted LNP enables precise in vivo CAR delivery, significantly lowering manufacturing costs
Our proprietary platform transforms drug discovery, tailored to complex targets.
